CytoMed Therapeutics
GDTC
#8291
Rank
$23.08 M
Marketcap
$2.00
Share price
-1.48%
Change (1 day)
-53.49%
Change (1 year)

Earnings for CytoMed Therapeutics (GDTC)

Earnings in 2022: -$2.25 M

According to CytoMed Therapeutics's latest financial reports the company's current earnings (TTM) are -$2.25 M. In 2022 the company made an earning of -$2.25 M a decrease over its 2021 earnings that were of -$1.44 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for CytoMed Therapeutics from 2020 to 2022

Annual earnings

Year Earnings Change
2022-$2.25 M57.04%
2021-$1.44 M3.42%
2020-$1.39 M